STR-324

N/A

Report date: 2024/11/23 20:00:08

NME

Base Information

Drug NameSTR-324

Drug Alias NameSTR-324

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionNeprilysin inhibitors

TargetsNeprilysin

Therapy Area/IndicationsAcute Pain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInstitute of Immunology and Infection, Chinese Academy of Sciences Shanghai

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlaxia Sas

Active IndicationsN/A

Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A

Related LinksN/A